Planned sale of 105,625 issuer common shares

Form 144 discloses a planned sale of 105,625 shares of common stock, with an aggregate market value of $950,625.00.

Accepted by SEC EDGAR 02/02/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Form 144 discloses a planned sale of 105,625 shares of common stock, with an aggregate market value of $950,625.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ around 02/02/2026.

The securities were acquired on 01/31/2026 as restricted stock units from the issuer, with the same date listed for payment and the nature of payment marked as N/A. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ZVRA Form 144 filing disclose about planned share sales?

The filing shows a planned sale of 105,625 common shares with an aggregate market value of $950,625.00. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ around 02/02/2026.

How were the 105,625 ZVRA shares in this Form 144 acquired?

The shares were acquired on 01/31/2026 as restricted stock units from the issuer. The table lists 105,625 securities acquired on that date, with the nature of payment shown as “N/A,” indicating no separate cash purchase price in this record.

Which broker is handling the planned ZVRA share sale in this Form 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filing lists this broker for executing the sale of 105,625 common shares on NASDAQ.

What market information is provided about the ZVRA shares in this Form 144?

The filing states an aggregate market value of $950,625.00 for the 105,625 common shares to be sold. It also specifies that the planned transaction will occur on the NASDAQ, giving investors context on venue and implied pricing of the proposed sale.

What representation does the seller make in the ZVRA Form 144 notice?

By signing, the seller represents they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement when filing a Form 144 notice of proposed sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001681098
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZEVRA THERAPEUTICS INC
SEC File Number	001-36913
Address of Issuer	1180 Celebration Boulevard, Suite 103 Celebration FLORIDA 34747
Phone	3219393416
Name of Person for Whose Account the Securities are To Be Sold	NEIL F MCFARLANE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	105625	950625.00	56297535	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted Stock Units	Issuer			105625	01/31/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were or will be acquired upon the vesting of restricted stock units during the period of 1/31/2026 through 2/7/2026.
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil F McFarlane
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)